EUPRAXIA PHARMACEUTICALS INC. Shareholders' Equity
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Shareholders' Equity of $82.04 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-13
- 2025-12-31: Stockholders' Equity Attributable to Parent $82.04M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $33.40M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $2.22M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $7.79M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $82.04M 40-F · filed 2026-03-13 |
| 2024-12-31 | $33.40M 40-F · filed 2026-03-13 |
| 2023-12-31 | $2.22M 40-F · filed 2025-03-20 |
| 2022-12-31 | $7.79M 40-F · filed 2024-04-01 |